Navigation Links
Pancreatic survival rates at standstill for 4 decades
Date:8/6/2014

Long-term survival from pancreatic cancer has failed to improve in 40 years with the outlook remaining the lowest of the 21 most common cancers, according to new figures published by Cancer Research UK today.

Today just over three per cent of pancreatic cancer patients survive for at least five years, only a fraction more than the two per cent who survived that long in the early 1970s.

Across all cancers, half of patients now survive at least twice that long. But most cases of pancreatic cancer go undetected until it is too late for surgery. And with the lack of effective tests and treatments for the disease, the majority of patients still die within a year.

But Cancer Research UK is planning to more than double its 6 million annual research spend on pancreas cancer within five years, making inroads into an area of research that until now has been globally neglected. The disease is now under the spotlight across the charity's five institutes nationwide.

Professor Andrew Biankin is among the three quarters of scientists at Cancer Research UK's Beatson Institute at the University of Glasgow who are contributing to pancreatic cancer research.

He said: "Pancreatic cancer has very few symptoms at first and I see far too many patients who, out of the blue, are told they may have just months or even weeks to live. We've been waiting too long for new drugs to treat the disease and there are very few options available for people with advanced forms of the disease. It's a situation that simply has to change and we can only do that by funding more high quality research and trials, to get treatments out of the lab and into patients as soon as possible."

Working with Professor Sean Grimmond, Professor Biankin is leading a team of researchers studying the unique pattern of faults in tumour samples from 400 pancreatic cancer patients and comparing this to their treatment and outcomes to create a map that will help guide the treatment of future patients.

They're also trying to identify molecules that could be used as early warning signs for the disease, to help diagnose patients before their cancer becomes too advanced.

Yasmin, 41, from London, lost her father Shaukat to pancreatic cancer in 2008. She said: "I lost my dad just 18 months after he was diagnosed with pancreatic cancer. I don't want other families to go through what we did.

"The more research we do, the more chances we have to find cures. Progress is being made but it's hard to cope with the fact that it couldn't help dad. By the time pancreatic cancer is diagnosed, it's often too late for treatment to work.

"I miss my dad every day. Life changes around you, things go on, but I'm always aware there's somebody missing."

Pancreatic cancer is the tenth most common cancer in the UK. Every year, around 8,800 people are diagnosed with the disease and around 8,300 die from it.

Harpal Kumar, Cancer Research UK's chief executive, said: "It's shocking that so many patients are still losing their lives to pancreatic cancer, which is why we've made it a priority to ignite a new wave of research that will see the disease detected earlier and much needed treatments getting to patients sooner.

"Overall, more than half of all cancer patients now survive at least a decade, which is testament to the power of research to transform people's lives. But disappointingly, we are nowhere near that level with pancreas cancer, and we won't stop until we can bring those kinds of results to all patients, regardless of their cancer type."


'/>"/>
Contact: Ailsa Stevens
ailsa.stevens@cancer.org.uk
020-346-98309
Cancer Research UK
Source:Eurekalert

Related medicine news :

1. Pyruvate oxidation is critical determinant of pancreatic islet number and β-cell mass
2. New trick for old drug brings hope for pancreatic cancer patients
3. Unique study focuses on combined treatment approach for locally advanced pancreatic cancer
4. GW researcher receives more than $1 million in grants to study epigenetics of pancreatic cancer
5. Continued use of low-dose aspirin may lower pancreatic cancer risk
6. New target: Researchers identify pancreatic cancer resistance mechanism
7. Vaccine reprograms pancreatic cancers to respond to immunotherapy
8. Virginia G. Piper Cancer Center vaccine study hopes to improve pancreatic cancer treatment
9. Endoscope with an oxygen sensor detects pancreatic cancer
10. Short nanotubes target pancreatic cancer
11. New therapy for pancreatic cancer patients shows promising results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... Springs, FL (PRWEB) , ... February 13, 2016 , ... ... the environmental impact of American businesses. , The increasingly modern world of instantaneous ... more often on non-renewable energy sources such as oil and coal, which pollutes our ...
(Date:2/13/2016)... ... 2016 , ... DDi , a Makro company, makes ... its expertise in eClinical Solutions. DDi has built its solution competency with a ... global clients. DDi provides smarter technology for Clinical Development, Regulatory and Enterprise domains ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Lymphoma Research ... lymphoma research and serving the lymphoma community through a comprehensive series of education ... Florida’s philanthropic community at its 10th anniversary Fashion Luncheon on Monday, February 8, ...
(Date:2/12/2016)... ... 12, 2016 , ... Coco Libre, the maker of coconut water beverages with ... Style Lounge Event. Coco Libre will offer musicians and celebrities the company’s signature Organic ... The invitation-only gifting suite, held this year at the W Hollywood Hotel, has become ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fisher House Foundation Chairman and ... J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy Kearns Director, VA ... Southern Nevada Healthcare System. This will be the first Fisher House in Nevada, ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Affairs leaders at pharmaceutical organizations are looking to either start or ... some companies have conducted a significant number of clinical trials in ... as India and China ... India are now requiring local clinical trials to win ... China and India are ...
(Date:2/12/2016)... , Feb. 12, 2016  Innophos Holdings, Inc. (NASDAQ: ... specialty ingredients, today announced that it will host a live ... ET to discuss its fourth quarter and full year 2015 ... The press release detailing fourth quarter and full year results ... close. --> --> ...
(Date:2/12/2016)... VIEJO , Kalifornien, 12. Februar 2016 /PRNewswire/ ... mit der Aufnahme von Patienten für eine Studie ... von Aneurysmen („WEB") speziell für die Behandlung von ... Spelle , MD, Leiter der Neuroradiologie an der ... Frankreich, und Hauptprüfarzt der CLARYS-Studie hat den ersten ...
Breaking Medicine Technology: